The role and utility of population-based cancer registries in cervical cancer surveillance and control.
Cervical cancer
Epidemiology
Global health
Public health surveillance
Registries
Journal
Preventive medicine
ISSN: 1096-0260
Titre abrégé: Prev Med
Pays: United States
ID NLM: 0322116
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
18
06
2020
revised:
03
08
2020
accepted:
12
08
2020
entrez:
8
3
2021
pubmed:
9
3
2021
medline:
29
6
2021
Statut:
ppublish
Résumé
Population-based cancer registries (PBCR) are vital to the assessment of the cancer burden and in monitoring and evaluating national progress in cervical cancer surveillance and control. Yet the level of their development in countries exhibiting the highest cervical cancer incidence rates is suboptimal, and requires considerable investment if they are to document the impact of WHO global initiative to eliminate cervical cancer as a public health problem. As a starting point we propose a comprehensive cancer surveillance framework, positioning PBCR in relation to other health information systems that are required across the cancer control continuum. The key concepts of PBCR are revisited and their role in providing a situation analysis of the scale and profile of the cancer-specific incidence and survival, and their evolution over time is illustrated with specific examples. Linking cervical cancer data to screening and immunization information systems enables the development of a comprehensive set of measures capable of assessing the short- and long-term achievements and impact of the initiative. Such data form the basis of national and global estimates of the cancer burden and permit comparisons across countries, facilitating decision-making or triggering cancer control action. The initiation and sustainable development of PBCR must be an early step in the scale-up of cervical cancer control activities as a means to ensure progress is successfully monitored and appraised.
Identifiants
pubmed: 33678223
pii: S0091-7435(20)30261-9
doi: 10.1016/j.ypmed.2020.106237
pmc: PMC7957339
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
106237Subventions
Organisme : CIHR
ID : 334069
Pays : Canada
Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Références
Lancet Oncol. 2017 Oct;18(10):e573-e586
pubmed: 28971824
Global Health. 2012 Oct 30;8:34
pubmed: 23110989
Br J Cancer. 2020 Jul;123(1):148-154
pubmed: 32336751
Am J Med. 2004 Oct 1;117(7):492-8
pubmed: 15464706
Lancet. 2014 Feb 8;383(9916):564-73
pubmed: 24351320
Lancet Oncol. 2019 Nov;20(11):1493-1505
pubmed: 31521509
Cancer Epidemiol. 2019 Apr;59:46-50
pubmed: 30685574
Med Teach. 2016 Jun;38(6):633
pubmed: 26310429
Lancet. 2015 Oct 3;386(10001):1395-1406
pubmed: 25971218
J Natl Cancer Inst. 2015 Apr 29;107(6):djv086
pubmed: 25925419
Prev Med. 2017 Oct;103:60-65
pubmed: 28765084
Eur J Cancer. 2015 May;51(8):950-68
pubmed: 25817010
Int J Cancer. 2018 Nov 1;143(9):2238-2249
pubmed: 29786136
Vaccine. 2018 Aug 6;36(32 Pt A):4816-4822
pubmed: 29571973
IARC Sci Publ. 1998;(145):135-73
pubmed: 10194635
Front Public Health. 2015 Jul 30;3:186
pubmed: 26284233
Lancet Infect Dis. 2007 Jul;7(7):453-9
pubmed: 17597569
Epidemiol Rev. 2017 Jan 1;39(1):161-169
pubmed: 28472440
BMC Med. 2020 Mar 9;18(1):74
pubmed: 32146900
IARC Sci Publ. 2011;(162):257-91
pubmed: 21675431
Oncologist. 2018 Aug;23(8):871-873
pubmed: 30049884
Int J Cancer. 2020 Sep 15;147(6):1629-1637
pubmed: 32142162
Eur J Public Health. 2019 Apr 1;29(2):345-350
pubmed: 30265313
Lancet. 2017 Feb 25;389(10071):847-860
pubmed: 27814965
Eur J Cancer. 2015 Jun;51(9):1039-49
pubmed: 25131265
Cancer Epidemiol. 2016 Dec;45 Suppl 1:S43-S49
pubmed: 27726981
BMC Health Serv Res. 2017 Oct 2;17(1):688
pubmed: 28969690
Cancer Epidemiol. 2014 Dec;38(6):748-56
pubmed: 25305098
PLoS One. 2014 Feb 05;9(2):e88323
pubmed: 24505474
Educ Health (Abingdon). 2001;14(3):395-404
pubmed: 14742004
Clin Infect Dis. 2018 Jan 18;66(3):339-345
pubmed: 29029053
Lancet Infect Dis. 2012 Oct;12(10):781-9
pubmed: 22920953
Cancer. 2008 Nov 15;113(10 Suppl):3047-57
pubmed: 18980287
Nat Rev Cancer. 2006 Aug;6(8):603-12
pubmed: 16862191
Int J Cancer. 2020 Sep 15;147(6):1638-1648
pubmed: 32150288
Int J Cancer. 2012 Nov 15;131(10):2349-59
pubmed: 22323075
Cancer. 2017 Dec 15;123 Suppl 24:5119-5137
pubmed: 29205300
Int J Cancer. 2018 Oct 1;143(7):1662-1670
pubmed: 29707775
Cancer Causes Control. 2012 Feb;23(2):281-8
pubmed: 22108842
J Womens Health (Larchmt). 2017 May;26(5):403-412
pubmed: 28513340
BMC Public Health. 2018 Dec 3;18(1):1329
pubmed: 30509233
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Crit Rev Oncol Hematol. 2008 Nov;68(2):131-56
pubmed: 18406622
MMWR Morb Mortal Wkly Rep. 2019 Apr 19;68(15):337-343
pubmed: 30998672
Eur J Cancer. 2009 Oct;45(15):2632-9
pubmed: 19709878
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
J Clin Microbiol. 2011 Oct;49(10):3537-44
pubmed: 21813716
Eur J Cancer. 2004 Dec;40(18):2794-803
pubmed: 15571963
Lancet. 2015 Mar 14;385(9972):977-1010
pubmed: 25467588
Cancer Causes Control. 2014 May;25(5):571-81
pubmed: 24578200
Vaccine. 2008 Aug 19;26 Suppl 11:L37-48
pubmed: 18945401
Lancet. 2015 Oct 3;386(10001):1386-1394
pubmed: 25971222
Int J Clin Oncol. 2008 Apr;13(2):102-11
pubmed: 18463952
Lancet Glob Health. 2020 Feb;8(2):e191-e203
pubmed: 31812369
Lancet. 2011 Jun 18;377(9783):2085-92
pubmed: 21684381
Colomb Med (Cali). 2018 Mar 30;49(1):23-34
pubmed: 29983461
Lancet Glob Health. 2020 Feb;8(2):e180-e190
pubmed: 31862245
Acta Oncol. 2012 Jan;51(1):45-50
pubmed: 22047060
Bull World Health Organ. 2019 Sep 01;97(9):637-641
pubmed: 31474777
J Med Screen. 2016 Dec;23(4):217-226
pubmed: 27068429
Lancet Oncol. 2019 Mar;20(3):394-407
pubmed: 30795950
Lancet. 2020 May 2;395(10234):1452-1456
pubmed: 32305072
Vaccine. 2015 Mar 10;33(11):1400-5
pubmed: 25573038
Int J Cancer. 2020 Dec 1;147(11):3037-3048
pubmed: 32449157
Nat Rev Clin Oncol. 2019 Dec;16(12):763-771
pubmed: 31388125
Eur J Cancer. 2015 Jan;51(2):241-51
pubmed: 25483785
Oncologist. 2015 Jun;20(6):627-34
pubmed: 25956407